Kapusta Matthew C 4

What Happened

• Matthew C. Kapusta, CEO and Managing Director of uniQure (QURE), exercised 21,082 stock options on July 2, 2026 at $19.39 per share (total cost $408,780) and sold all 21,082 shares in open-market transactions the same day for aggregate proceeds of approximately $952,051. The transactions were effected under a pre-established Rule 10b5-1 sales plan.
• Net cash received from the sequence (gross sales minus exercise cost) was about $543,271. The reported option had vested in full on January 26, 2022.

Key Details

• Transaction date: July 2, 2026; Form 4 filed July 7, 2026 (appears to be filed after the usual two-business-day deadline).
• Exercise: 21,082 shares at $19.39 each = $408,780 (transaction code M).
• Sales (all on July 2, 2026):
  • 9,200 shares at weighted avg $44.43 (range $44.10–$44.80) — $408,756
  • 4,282 shares at weighted avg $45.43 (range $45.00–$45.95) — $194,531
  • 7,600 shares at weighted avg $45.89 (range $45.48–$46.10) — $348,764
  • Total sold: 21,082 shares for ~$952,051.
• Footnotes: F1 indicates sales were under a Rule 10b5-1 plan; F5 notes the option vested on Jan 26, 2022. Several footnotes detail weighted-average price ranges for the multiple sale trades.
• Shares owned after the transaction: not specified in the provided filing details.

Context

• This was effectively a cashless exercise and immediate sale: Kapusta exercised options and sold those same shares the same day, which is typically a liquidity event rather than a directional “buy” signal.
• The use of a 10b5-1 plan means the sales were prearranged; that can reduce (but does not eliminate) the informational content of the sale about the insider’s current view.
• The filing date suggests the Form 4 was submitted after the standard two-business-day reporting window, which may be noted by regulators or investors tracking timeliness.